Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Cancer

Explore clinical trials studying Renal Cell Cancer. Study availability and eligibility vary by location and protocol.

53 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Cancer trial results

Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

NCT02493751

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Scottsdale Healthcare Hospitals d/b/a HonorHealth Scottsdale, Arizona, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

NCT02655822

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
View all 20 locations
View Trial Details
Completed

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

NCT01631552

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +78 more
Locations
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Helen F. Graham Cancer Center Newark, Delaware, United States
  • MD Anderson Cancer Center Orlando (UF Health Cancer Center) Orlando, Florida, United States
View Trial Details
Completed

NANOTECH RCC Biomarkers

NCT02923284

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Washington University St Louis School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions